An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...

Overall, women with more advanced MS disability had similar peripartum relapse activity as those with less disability, ...

So welcome to our Pharma Day 2025 here in London. It's good to see here full house. I was told we have, I think, a record attendance here on site, and we also have quite a high number, I think, of web ...

Healthy’ woman diagnosed with rare autoimmune disorder after rash - Tia Rey now struggles to walk or stand for long periods and is often breathless ...

After numerous blood tests and support from a rheumatology specialist, Ms Rey was diagnosed with antisynthetase syndrome, a rare autoimmune disorder causing painful muscle inflammation and arthritis.

Some older adults with MS on disease-modifying therapies, mainly patients 60 and older, may be able to discontinue DMTs if ...

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition.

The McDonald criteria revisions provide a unified approach for diagnosing MS from pediatric to late-life presentations, said ...

Dr Jiwon Oh looks forward to hearing updates on major clinical trials and long-term studies of new and emerging MS treatments at ECTRIMS 2025.

Better diagnostics and more treatment options have modestly improved interstitial lung disease management in patients with ...

The latest revisions to the McDonald criteria seek to provide a unified framework for the most accurate diagnosis of MS ...

Almost half of women with MS remain untreated during family planning, though ocrelizumab is the most commonly used DMT in this population.